Clinical Trial

Pain with Differing Intraperitoneal Washes At the End of Laparoscopic Gynecologic Surgery

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 24, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
We hypothesize that instilling intraperitoneal Marcaine (without epinephrine) at the end of a non-total laparoscopic gynecologic surgery (adnexa only, which includes the ovaries, fallopian tubes, and associated ligaments, vessels, and connective tissue) will result in less pain and reduced opioid use postoperatively.
Trial Details
NCT Number NCT06842771
Lead Sponsor University of Tennessee
Conditions Laparoscopic Adnexal Surgery
Enrollment 96 participants
Start Date 2025-03
Primary Completion 2026-02 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2025-02-24